» Authors » Harald Eidherr

Harald Eidherr

Explore the profile of Harald Eidherr including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 202
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rasul S, Wollenweber T, Zisser L, Kretschmer-Chott E, Grubmuller B, Kramer G, et al.
Cancers (Basel) . 2021 Jun; 13(10). PMID: 34065303
Background: We investigated the response rate and degree of toxicity of a second course of three cycles of [Lu]Lu-PSMA radioligand therapy (PSMA-RLT) every 4 weeks in mCRPC patients. Methods: Forty-three...
2.
Mayerhoefer M, Prosch H, Beer L, Tamandl D, Beyer T, Hoeller C, et al.
Eur J Nucl Med Mol Imaging . 2019 Aug; 47(1):51-60. PMID: 31410538
Purpose: PET/MRI has recently been introduced into clinical practice. We prospectively investigated the clinical impact of PET/MRI compared with PET/CT, in a mixed population of cancer patients, and performed an...
3.
Grubmuller B, Senn D, Kramer G, Baltzer P, DAndrea D, Grubmuller K, et al.
Eur J Nucl Med Mol Imaging . 2018 Dec; 46(5):1063-1072. PMID: 30569186
Purpose: The first aim of this study was to evaluate Ga-PSMA conjugate 11 positron emission tomography (PSMA PET) parameters for assessment of response to Lu-PSMA-617 radioligand therapy (RLT) in patients...
4.
Pichler V, Vraka C, Berroteran-Infante N, Krcal A, Eidherr H, Traub-Weidinger T, et al.
Appl Radiat Isot . 2018 Sep; 141:107-111. PMID: 30196247
Radiosynthetic optimization is crucial in routine PET production but is often neglected in literature. Small changes in the radiochemical procedure can increase the yield significantly and reduce time fluctuation within...
5.
Mayerhoefer M, Ba-Ssalamah A, Weber M, Mitterhauser M, Eidherr H, Wadsak W, et al.
Eur Radiol . 2013 Mar; 23(7):1978-85. PMID: 23471430
Objectives: To compare fused gadoxetate-enhanced Ga-68-DOTANOC PET/MRI and Ga-68-DOTANOC PET/DWI (diffusion-weighted imaging) for the assessment of abdominal neuroendocrine tumours (NETs). Methods: Eighteen patients with suspected or histologically proven NETs of...
6.
Hoffmann M, Troch M, Eidherr H, Traub-Weidinger T, Jonak C, Muellauer L, et al.
Leuk Lymphoma . 2010 Dec; 52(1):42-5. PMID: 21133720
Radioimmunotherapy using (90)Y-ibritumomab tiuxetan has predominantly been used in patients with follicular lymphoma, but little is known about its activity in patients with extranodal marginal zone lymphoma of the mucosa...
7.
Wadsak W, Mien L, Ettlinger D, Eidherr H, Haeusler D, Sindelar K, et al.
Nucl Med Biol . 2007 Nov; 34(8):1019-28. PMID: 17998107
Introduction: The translation of 11C-labeled compounds into their respective 18F-labeled derivatives is an important tool in the rapid development of positron emission tomography (PET) tracers. Thus, our aim was the...
8.
Toegel S, Wadsak W, Mien L, Viernstein H, Kluger R, Eidherr H, et al.
Eur J Pharm Biopharm . 2007 Jul; 68(2):406-12. PMID: 17611088
Purpose: The present study aimed to develop convenient preparation and quality control protocols for [(68)Ga]-EDTMP, a potential radiotracer for skeletal PET imaging. Furthermore, bone binding characteristics with special focus on...
9.
Mitterhauser M, Toegel S, Wadsak W, Lanzenberger R, Mien L, Kuntner C, et al.
Nucl Med Biol . 2007 May; 34(4):391-7. PMID: 17499728
Introduction: The objectives of this study were to develop a simple preparation method for [68Ga]-EDTMP and to evaluate the applicability of [68Ga]-EDTMP as a potential positron emission tomography (PET) bone...
10.
Toegel S, Mien L, Wadsak W, Eidherr H, Viernstein H, Kluger R, et al.
Nucl Med Biol . 2006 Feb; 33(1):95-9. PMID: 16459264
The present study focused on the preparation of novel bone tracers containing yttrium as radionuclide or carrier. Moreover, these preparations were comparatively evaluated in vitro on the basis of a...